Search

Categories

    • categories-img Jacket, Women
    • categories-img Woolend Jacket
    • categories-img Western denim
    • categories-img Mini Dresss
    • categories-img Jacket, Women
    • categories-img Woolend Jacket
    • categories-img Western denim
    • categories-img Mini Dresss
    • categories-img Jacket, Women
    • categories-img Woolend Jacket
    • categories-img Western denim
    • categories-img Mini Dresss
    • categories-img Jacket, Women
    • categories-img Woolend Jacket
    • categories-img Western denim
    • categories-img Mini Dresss
    • categories-img Jacket, Women
    • categories-img Woolend Jacket
    • categories-img Western denim
    • categories-img Mini Dresss

Filter By Price

$
-
$

Dietary Needs

Top Rated Product

product-img product-img

Modern Chair

$165.00
product-img product-img

Plastic Chair

$165.00
product-img product-img

Design Rooms

$165.00

Brands

  • Wooden
  • Chair
  • Modern
  • Fabric
  • Shoulder
  • Winter
  • Accessories
  • Dress

Welcome and thank you for visiting us. For any query call us on 0799 626 359 or Email [email protected]

Shopping Cart

Africa largest book store

Sub Total:

Search for any Title

Results for: and Translation Forum on Drug Discovery Development

  • Home
  • and Translation Forum on Drug Discovery Development

Showing 1 to 34 of 34 (1 Pages)

The New Profile of Drug-Resistant Tuberculosis in Russia

The New Profile of Drug-Resistant Tuberculosis in Russia

by Board on Health Sciences Policy
Ksh 6,850
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

by Board on Health Sciences Policy
Ksh 5,600
Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics

Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics

by Board on Health Care Services
Ksh 3,950
International Regulatory Harmonization Amid Globalization of Drug Development

International Regulatory Harmonization Amid Globalization of Drug Development

by Board on Health Sciences Policy
Ksh 7,200
Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance

Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance

by Board on Global Health
Ksh 4,150
Adult Attention-Deficit/Hyperactivity Disorder

Adult Attention-Deficit/Hyperactivity Disorder

by Board on Health Sciences Policy
Ksh 4,300
The Role of Digital Health Technologies in Drug Development

The Role of Digital Health Technologies in Drug Development

by Board on Health Sciences Policy
Ksh 11,700
Breakthrough Business Models

Breakthrough Business Models

by Board on Health Sciences Policy
Ksh 8,800
Drug Research and Development for Adults Across the Older Age Span

Drug Research and Development for Adults Across the Older Age Span

by Board on Health Care Services
Ksh 7,200
Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting

Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting

by Board on Health Care Services
Ksh 10,450
Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

by Board on Health Sciences Policy
Ksh 8,650
Enabling Precision Medicine

Enabling Precision Medicine

by Board on Health Sciences Policy
Ksh 10,800
Inclusion of Pregnant and Lactating Persons in Clinical Trials

Inclusion of Pregnant and Lactating Persons in Clinical Trials

by Board on Health Sciences Policy
Ksh 4,150
Addressing the Barriers to Pediatric Drug Development

Addressing the Barriers to Pediatric Drug Development

by Board on Health Sciences Policy
Ksh 5,200
The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

by Academy of Science of South Africa
Ksh 8,650
Real-World Evidence Generation and Evaluation of Therapeutics

Real-World Evidence Generation and Evaluation of Therapeutics

by Board on Health Sciences Policy
Ksh 9,900
Facing the Reality of Drug-Resistant Tuberculosis in India

Facing the Reality of Drug-Resistant Tuberculosis in India

by Board on Health Sciences Policy
Ksh 9,350
Advancing the Discipline of Regulatory Science for Medical Product Development

Advancing the Discipline of Regulatory Science for Medical Product Development

by Board on Health Sciences Policy
Ksh 7,200
Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

by Board on Health Sciences Policy
Ksh 8,100
Public Engagement and Clinical Trials

Public Engagement and Clinical Trials

by Board on Health Sciences Policy
Ksh 7,400
Envisioning a Transformed Clinical Trials Enterprise in the United States

Envisioning a Transformed Clinical Trials Enterprise in the United States

by Board on Health Sciences Policy
Ksh 8,800
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

by Board on Health Sciences Policy
Ksh 8,450
Envisioning a Transformed Clinical Trials Enterprise for 2030

Envisioning a Transformed Clinical Trials Enterprise for 2030

by Board on Health Sciences Policy
Ksh 5,400
Sharing Clinical Research Data

Sharing Clinical Research Data

by Board on Health Care Services
Ksh 7,550
Understanding the Benefits and Risks of Pharmaceuticals

Understanding the Benefits and Risks of Pharmaceuticals

by Board on Health Sciences Policy
Ksh 5,200
Direct-To-Consumer Genetic Testing

Direct-To-Consumer Genetic Testing

by Board on Health Sciences Policy
Ksh 7,000
The Public Health Emergency Medical Countermeasures Enterprise

The Public Health Emergency Medical Countermeasures Enterprise

by Board on Health Sciences Policy
Ksh 10,600
Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

by Board on Health Sciences Policy
Ksh 8,100
Defining and Evaluating In-Home Drug Disposal Systems For Opioid Analgesics

Defining and Evaluating In-Home Drug Disposal Systems For Opioid Analgesics

by Board on Health Sciences Policy
Ksh 3,950
Challenges for the FDA

Challenges for the FDA

by Board on Health Sciences Policy
Ksh 7,900
Rapid Medical Countermeasure Response to Infectious Diseases

Rapid Medical Countermeasure Response to Infectious Diseases

by Board on Global Health
Ksh 9,000
Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

by Board on Health Sciences Policy
Ksh 8,100
Accelerating the Development of Biomarkers for Drug Safety

Accelerating the Development of Biomarkers for Drug Safety

by Board on Health Sciences Policy
Ksh 5,200
Virtual Clinical Trials

Virtual Clinical Trials

by Board on Health Sciences Policy
Ksh 9,900